These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 26168700)

  • 1. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.
    Sellmann C; Priebs J; Landmann M; Degen C; Engstler AJ; Jin CJ; Gärttner S; Spruss A; Huber O; Bergheim I
    J Nutr Biochem; 2015 Nov; 26(11):1183-92. PubMed ID: 26168700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment.
    Brandt A; Jin CJ; Nolte K; Sellmann C; Engstler AJ; Bergheim I
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
    Spruss A; Kanuri G; Wagnerberger S; Haub S; Bischoff SC; Bergheim I
    Hepatology; 2009 Oct; 50(4):1094-104. PubMed ID: 19637282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).
    Sellmann C; Jin CJ; Engstler AJ; De Bandt JP; Bergheim I
    Eur J Nutr; 2017 Dec; 56(8):2519-2527. PubMed ID: 27496089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis.
    Wagnerberger S; Spruss A; Kanuri G; Volynets V; Stahl C; Bischoff SC; Bergheim I
    Br J Nutr; 2012 Jun; 107(12):1727-38. PubMed ID: 22018861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice.
    Haub S; Kanuri G; Volynets V; Brune T; Bischoff SC; Bergheim I
    Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G335-44. PubMed ID: 19713474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH).
    Jin CJ; Sellmann C; Engstler AJ; Ziegenhardt D; Bergheim I
    Br J Nutr; 2015 Dec; 114(11):1745-55. PubMed ID: 26450277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice.
    Spruss A; Kanuri G; Uebel K; Bischoff SC; Bergheim I
    Antioxid Redox Signal; 2011 Jun; 14(11):2121-35. PubMed ID: 21083420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function.
    Spruss A; Kanuri G; Stahl C; Bischoff SC; Bergheim I
    Lab Invest; 2012 Jul; 92(7):1020-32. PubMed ID: 22525431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice.
    Sellmann C; Baumann A; Brandt A; Jin CJ; Nier A; Bergheim I
    J Nutr; 2017 Nov; 147(11):2041-2049. PubMed ID: 28931589
    [No Abstract]   [Full Text] [Related]  

  • 11. Green tea extract protects against hepatic NFκB activation along the gut-liver axis in diet-induced obese mice with nonalcoholic steatohepatitis by reducing endotoxin and TLR4/MyD88 signaling.
    Li J; Sasaki GY; Dey P; Chitchumroonchokchai C; Labyk AN; McDonald JD; Kim JB; Bruno RS
    J Nutr Biochem; 2018 Mar; 53():58-65. PubMed ID: 29190550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with alpha-galactosylceramide protects mice from early onset of nonalcoholic steatohepatitis: Role of intestinal barrier function.
    Engstler AJ; Sellmann C; Jin CJ; Brandt A; Herz K; Priebs J; Bergheim I
    Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 28067024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet.
    Ushio M; Nishio Y; Sekine O; Nagai Y; Maeno Y; Ugi S; Yoshizaki T; Morino K; Kume S; Kashiwagi A; Maegawa H
    Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E293-304. PubMed ID: 23715726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis.
    Baumann A; Jin CJ; Brandt A; Sellmann C; Nier A; Burkard M; Venturelli S; Bergheim I
    Nutrients; 2020 Mar; 12(4):. PubMed ID: 32235497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. fat-1 mice prevent high-fat plus high-sugar diet-induced non-alcoholic fatty liver disease.
    Guo XF; Gao JL; Li JM; Li D
    Food Funct; 2017 Nov; 8(11):4053-4061. PubMed ID: 28972610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
    Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
    BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response.
    Spruss A; Henkel J; Kanuri G; Blank D; Püschel GP; Bischoff SC; Bergheim I
    Mol Med; 2012 Dec; 18(1):1346-55. PubMed ID: 22952059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics attenuate diet-induced nonalcoholic fatty liver disease without altering intestinal barrier dysfunction.
    Brandt A; Csarmann K; Hernández-Arriaga A; Baumann A; Staltner R; Halilbasic E; Trauner M; Camarinha-Silva A; Bergheim I
    J Nutr Biochem; 2024 Jan; 123():109495. PubMed ID: 37871765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.
    Rahman K; Desai C; Iyer SS; Thorn NE; Kumar P; Liu Y; Smith T; Neish AS; Li H; Tan S; Wu P; Liu X; Yu Y; Farris AB; Nusrat A; Parkos CA; Anania FA
    Gastroenterology; 2016 Oct; 151(4):733-746.e12. PubMed ID: 27342212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.